Part of a streamlined range of vaccines with a straightforward protocol to provide excellent protection against core feline diseases
Leucogen® is the World’s first recombinant subunit vaccine containing purified p45 FeLV-envelope antigen identified as the most important antigen for stimulating immunity to FeLV.
Product Features & Benefits:
Provides targeted effective antigenic challenge
3 year duration of immunity
Proven efficacy and safety2,3
Recombinant subunit FeLV vaccine
Protects against all 3 subgroups of FeLV
Available in 10 or 50 doses.
Use medicines responsibly. www.noah.co.uk/responsible.
Further information is available on the SPC or on request from Virbac Ltd.